acute rejection kidney transplantation renal biopsy immunosuppression As the interest in telehealth and remote monitoring increases,1 many transplant practitioners have turned to donor-derived cell-free DNA (dd-cfDNA) to noninvasively monitor the immunologic status of allografts. As use of this testing grows, it is important to highlight limitations in its predictive value. There are several available dd-cfDNA tests.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with R. John
Contact R. John, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack